| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | NORBY R DOUGLAS | Director | May 09, 2018 | Buy | $10.42 | 9,000 | 93,780 | 9,000 | May 11, 2018, 04:27 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Sep 23, 2016 | Option Exercise | $129.94 | 15,500 | 2,014,105 | 11,174 | Sep 27, 2016, 05:14 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 11, 2015 | Option Exercise | $33.78 | 45,442 | 1,535,039 | 77,923 | Dec 15, 2015, 05:36 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 11, 2015 | Sale | $187.71 | 45,442 | 8,530,124 | 77,889 | Dec 15, 2015, 05:36 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | May 22, 2013 | Option Exercise | $13.89 | 40,000 | 555,490 | 96,144 | May 23, 2013, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | May 22, 2013 | Sale | $102.77 | 40,000 | 4,110,712 | 71,940 | May 23, 2013, 05:03 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 10, 2012 | Option Exercise | $6.81 | 22,000 | 149,830 | 60,673 | Dec 12, 2012, 06:19 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 10, 2012 | Sale | $93.00 | 22,000 | 2,046,000 | 38,673 | Dec 12, 2012, 06:19 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 09, 2012 | Sale | $85.01 | 28,300 | 2,405,783 | 30,743 | Mar 12, 2012, 05:14 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 08, 2012 | Option Exercise | $8.18 | 1,700 | 13,906 | 32,443 | Mar 12, 2012, 05:14 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 08, 2012 | Sale | $85.00 | 1,700 | 144,500 | 30,743 | Mar 12, 2012, 05:14 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 09, 2012 | Option Exercise | $8.18 | 28,300 | 231,494 | 59,043 | Mar 12, 2012, 05:14 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 28, 2011 | Option Exercise | $5.19 | 26,120 | 135,666 | 53,748 | Oct 31, 2011, 05:11 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 28, 2011 | Sale | $68.00 | 26,120 | 1,776,160 | 27,628 | Oct 31, 2011, 05:11 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 27, 2011 | Option Exercise | $5.55 | 18,880 | 104,784 | 46,508 | Oct 31, 2011, 05:11 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 27, 2011 | Sale | $68.00 | 18,880 | 1,283,840 | 27,628 | Oct 31, 2011, 05:11 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Feb 14, 2011 | Option Exercise | $7.43 | 23,000 | 170,910 | 36,814 | Feb 16, 2011, 04:28 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Feb 14, 2011 | Sale | $89.93 | 23,000 | 2,068,390 | 13,814 | Feb 16, 2011, 04:28 PM |
Menu